MS4A15 inhibitors are a class of chemical compounds that selectively target the MS4A15 protein, which belongs to the Membrane-Spanning 4A (MS4A) family. This protein family is characterized by its four transmembrane domains, and its members are involved in various cellular processes, particularly in cell signaling and membrane trafficking. MS4A15, like other MS4A proteins, plays a role in the regulation of cellular communication by influencing signal transduction pathways. By inhibiting the function of MS4A15, these compounds can interfere with its ability to mediate interactions at the cell membrane, potentially altering downstream signaling events and impacting cellular behavior.
The development of MS4A15 inhibitors requires a deep understanding of the protein's structural and functional characteristics. Inhibitors are typically designed to interact with key domains of MS4A15, such as its transmembrane regions or intracellular loops, preventing the protein from engaging in its normal interactions with other proteins or cellular components. Researchers use computational modeling, biochemical assays, and structural biology techniques to optimize the affinity and specificity of these inhibitors. The selectivity of MS4A15 inhibitors is essential, as it ensures that only MS4A15 is affected, minimizing any unintended effects on other MS4A family proteins or unrelated targets. Through inhibition of MS4A15, these compounds can impact various cellular pathways related to signal transduction, membrane organization, and other processes in which MS4A15 is involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
As a folate analog, it inhibits dihydrofolate reductase and can suppress DNA synthesis, potentially reducing MS4A15 expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
It is a pyrimidine analog that can inhibit thymidylate synthase, potentially leading to reduced MS4A15 expression. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and can disrupt cell division, which may indirectly affect MS4A15 protein levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that affects protein degradation pathways, possibly influencing MS4A15 protein stability. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Acts as a histone deacetylase inhibitor, potentially affecting chromatin structure and gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
By activating nuclear receptors, it can influence gene expression, which could theoretically affect MS4A15. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
While used primarily for malaria, it can alter lysosomal pH, potentially affecting protein degradation. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, reducing DNA synthesis, which could lower MS4A15 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits DNA topoisomerase II, leading to DNA damage and potentially affecting gene expression. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
As a kinase inhibitor, it may disrupt various signaling pathways and potentially downregulate MS4A15 expression. | ||||||